Profile
Mr. Ian Davenport is Operating Advisor at Ennovance Capital LLC.
Prior to joining Ennovance, Mr. Davenport was a Senior Executive at Dow Chemical with P&L responsibility (now a $1B+ business) and over 25 years of general leadership experience.
He held various senior management positions ranging from Global Business Director to Global Sales & Marketing to General Management.
His achievements include major business turnarounds, repeated successes in new business development, and the development and implementation of strategies leading to value creating acquisitions.
Mr. Davenport holds a B.A. & M.A. in Natural Sciences in Chemistry from Cambridge University.
Ian Davenport active positions
| Companies | Position | Start |
|---|---|---|
Ennovance Capital LLC
Ennovance Capital LLC Investment ManagersFinance Ennovance Capital invests in middle market companies located in the United States. The firm focuses on companies operating in the fields of chemicals, allied products, healthcare and related specialty material sectors. It provides financing for growth stage capital requirements with investment size of USD 200 million and above. | Private Equity Investor | - |
Former positions of Ian Davenport
| Companies | Position | End |
|---|---|---|
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - |
Training of Ian Davenport
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ennovance Capital LLC
Ennovance Capital LLC Investment ManagersFinance Ennovance Capital invests in middle market companies located in the United States. The firm focuses on companies operating in the fields of chemicals, allied products, healthcare and related specialty material sectors. It provides financing for growth stage capital requirements with investment size of USD 200 million and above. | Finance |
- Stock Market
- Insiders
- Ian Davenport
















